Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PENG Block in Primary Total Hip Arthroplasty
NCT06557044Recruiting
- Sponsor
- Diakonie-Klinikum Stuttgart
- Start
- Mar 2024
- Primary completion
- Mar 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of ropivacaine in postoperative pain (2 arms), sponsored by Diakonie-Klinikum Stuttgart. Primary endpoint: Rate of postoperative opioid administration. Started Mar 2024; status: recruiting.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06557044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06557044.